← All trials
NCT05922306
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 31, 2023
- Primary completion
- Jun 30, 2027
- Completion date
- Dec 31, 2027
- First posted
- Jun 28, 2023
- Last posted
- Jun 28, 2023
- Enrollment
- 1084
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Anhui Medical UniversityLead sponsor
- Anhui Medical UniversityReponsible party - principal investigator
- Bengbu Medical CollegeCollaborator
- Anhui Medical UniversityStudy chair
- Anhui Medical UniversityCollaborator
- Anhui Medical UniversityOfficial
- Anhui Medical UniversitySponsor investigator
- University of Science and Technology of ChinaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.